Patent · US Active

Botulinum toxin formulation

US9050336B2 · kind B2 · utility

23Cited by

33References

7Claims

0Family size

Assignee

Allergan, Inc. · US

Inventors

Wendy M. Blanda · Tustin, US
Roger K. Aoki · Coto De Caza, US
Terrence J. Hunt · Corona, US
Patrick M. Hughes · Aliso Viejo, US
James N. Chang · Newport Beach, US
Scott M. Whitcup · Laguna Hills, US
Michael R. Robinson · Irvine, US

Key dates

Filing date	May 8, 2012
Grant date	Jun 9, 2015
Priority date	—
Expiry date	May 7, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y304/24069
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Botulinum neurotoxin formulated with a hyaluronic acid carrier with increased residency time of the botulinum toxin at a subdermal location and fewer botulinum toxin induced complications or side effects.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.